Exploring the links between obesity and its adverse health outcomes

• Professor Sir Stephen O’Rahilly  Wellcome-MRC Institute of Metabolic Science, University of Cambridge, UK
• Professor David Savage  Wellcome-MRC Institute of Metabolic Science, University of Cambridge, UK

Confirmed speakers

• Kendra Bence, Pfizer, USA
• Jens Brüning, Max Planck Institute for Metabolism Research, Germany
• Sheila Collins, Vanderbilt University Medical Center, USA
• Anthony W Ferrante, Noami Berrie Diabetes Center, USA
• Gerald Shulman, Yale Diabetes Research Center, USA
• David James, University of Sydney, Australia
• James Johnson, University of British Columbia, Vancouver, Canada
• Barbara Kahn, Beth Israel Deaconess Medical Center, Harvard Medical School, USA
• Fredrik Karpe, Oxford Centre for Diabetes, Endocrinology and Metabolism, UK
• Dominique Langin, Metabolic and Cardiovascular Research Institute, INSERM, France
• Ruth Loos, Icahn School of Medicine, Mount Sinai, New York, USA
• Luca Lotta, Regeneron Pharmaceutical Inc, USA
• Bettina Mittendorfer, Washington University, USA
• Catherine Postic, Institut Cochin, France
• Ethan Weiss, Third Rock Ventures, USA
• Hannele Yki-Järvinen, University of Helsinki, Finland
• Anja Zeigerer, Helmholtz Munich, Germany

Call for papers

Short talk slots and poster presentations places are available. Abstracts can be submitted during online registration.

• Short talk abstract deadline: November 1, 2023
• Poster abstract deadline: February 1, 2024
• Download abstract guidelines